Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
01/2007
01/17/2007EP1743886A1 Method of inhibiting neurotrophin-receptor binding
01/17/2007EP1742920A2 Naphthalimide derivatives for the treatment of cancer
01/17/2007EP1537110B1 Triazospiro compounds having nociceptin receptor affinity
01/17/2007EP1341793B1 Crf receptor antagonists and methods relating thereto
01/17/2007CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
01/17/2007CN1896074A Fluorescent molecular probe and use for inspecting transient metal and heavy metal ion
01/17/2007CN1295219C Red light emitting naphthyl imide compound and its synthetic method
01/16/2007US7164022 Process for the preparation of pure Finasteride
01/11/2007WO2005076815A3 PERYLENE n-TYPE SEMICONDUCTORS AND RELATED DEVICES
01/11/2007US20070010571 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
01/11/2007CA2613068A1 Indole carboxamides as ikk2 inhibitors
01/10/2007EP1740548A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
01/10/2007EP1740149A1 Composition comprising a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound and a polymer containing said monomer compound and the use thereof
01/10/2007CN1894256A Method for preparing spironolactone compounds
01/10/2007CN1894249A Spiropiperidine derivatives for controlling pests
01/10/2007CN1894244A Aryl ether substituted imidazoquinolines
01/09/2007US7160887 Aromatic amine derivatives, their production and use
01/09/2007CA2344248C 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
01/04/2007WO2007002254A2 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
01/04/2007WO2007000465A1 Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
01/04/2007WO2007000464A1 Novel 3-aza-spiro[5.5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
01/04/2007US20070004714 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
01/03/2007EP1737857A1 Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
01/03/2007EP1737458A2 R(-)-11-hydroxyaporphine derivatives and uses thereof
01/03/2007EP1221439B1 Tetrahydroquinoline derivatives
01/03/2007CN1890248A Novel compounds
01/03/2007CN1890240A Diazabicyclononene derivatives and their use as renin inhibitors
01/03/2007CN1890238A Hydronopol derivatives as agonists on human ORL1 receptors
01/03/2007CN1293080C Process for the preparation of clopidogrel
01/03/2007CN1293078C Imidazo fused compounds
01/03/2007CN1293074C Arylindenopyridines with PDE inhibiting activity
01/03/2007CN1293070C Quinoline derivatives
01/02/2007US7157452 Substituted 4,9-dihydrocyclopenta{imn}phenanthridine-5-ones derivatives thereof and their uses
01/02/2007CA2412170C Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same
01/02/2007CA2344350C 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
01/02/2007CA2315909C Novel acronycine derivatives, preparation method and pharmaceutical compositions
12/2006
12/28/2006WO2006136063A1 Aporphine and secoaporphine compounds for treatment of diabetes
12/28/2006US20060293358 Tyrosine kinase inhibitors
12/27/2006EP1735281A2 Synthesis of indenoisoquinoliniums and methods of use
12/27/2006EP1734964A1 17 beta-acetamide-4-azasteroids as androgen receptor modulators
12/27/2006EP1534682B1 Novel molecules derived from noraporphine
12/27/2006CN1884265A Aporphine for treating diabetes mellitus and aporphine compounds
12/27/2006CN1291989C Method for separating lycorine from plant extract
12/27/2006CN1291983C Luminescent element material and luminescent element comprising the same
12/26/2006US7153872 Cancer and fibrotic diseases
12/21/2006WO2006133821A1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5
12/21/2006WO2006133805A1 Tetrahydroquinoline derivatives
12/21/2006US20060287351 Antibiotic cycloalkyltetrahydroquinoline derivatives
12/21/2006US20060287348 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease
12/21/2006US20060287327 androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness; LHRH (luteinizing hormone-releasing hormone) modulator
12/21/2006US20060287326 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators
12/21/2006US20060287313 Isoquinoline compounds and methods of use thereof
12/21/2006US20060287311 Tetracyclic Sulfonamide Compounds and methods of use thereof
12/21/2006CA2611893A1 Tetrahydroquinolines for use as modulators of the mitotic motor protein eg5
12/21/2006CA2611892A1 Tetrahydroquinoline derivatives as motor protein eg5 inhibitors and antitumor agents
12/20/2006EP1732928A2 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
12/20/2006EP1732899A2 Process for preparing cyclohexanediacetic acid monoamide
12/20/2006EP1732893A2 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
12/20/2006EP1732865A1 Fluoridation method
12/20/2006EP1732541A2 Cyclic compounds
12/20/2006EP1539164B1 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
12/20/2006EP1274688B1 Synthesis of intermediates useful in preparing tricyclic compounds
12/20/2006CN1882586A 1H-imidazo[4,5-C]quinoline derivatives in the treatment of protein kinase dependent diseases
12/20/2006CN1882585A Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
12/20/2006CN1880313A Novel heterocycle naphthoylimine and double-chain compound and its uses in tumour cell
12/20/2006CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/20/2006CN1290849C Compound of benzopyran category marked by fluorin [*F] as well as preparation method and its application of developing agent for D4 receptor of dopamine
12/19/2006US7151104 Pyrazolopyridines as cyclin dependent kinase inhibitors
12/19/2006CA2159091C Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses
12/14/2006WO2006132192A1 Novel 2-quinolone derivative
12/14/2006US20060281761 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/13/2006EP1730103A1 Formamide derivatives useful as adrenoceptor
12/13/2006EP1729723A1 Neutral and cationic naphthalene derivatives and dyes containing said compounds for dyeing keratin fibers
12/13/2006CN1878761A Arylindenopyridines and arylindenopyridines and their use as adenosine A2a receptor antagonist
12/13/2006CN1878758A Crf antagonists and heterobicyclic compounds
12/13/2006CN1876634A Sinomenine structure-modified compound and its preparation method
12/12/2006US7148352 Method of inhibiting neurotrophin-receptor binding
12/12/2006US7148351 Antiscaling agents
12/12/2006US7148232 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
12/07/2006WO2006129679A1 Spiropiperidine compound and medicinal use thereof
12/07/2006US20060276487 New compounds useful for DPP-IV enzyme inhibition
12/07/2006US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006US20060273819 Antibiotic tetrahydro-beta-carboline derivatives
12/07/2006US20060272546 N,N'-diphenyl- or N,N'-dianilino-3,4,9,10-Perylenetetracarboxylic diimides in which the phenyl rings are are substituted with sulfo, carboxy, phosphato or poly(ethylene oxide) groups; excellent ozone fastness
12/06/2006EP1728784A1 Fluorene derivative
12/06/2006EP1727819A1 Novel dichloro-phenyl-pyrido¬2,3-d|pyrimidine derivatives, their manufacture and use as pharmaceutical agents
12/06/2006CN1872859A Compound of heterocyclic pyridine class
12/06/2006CN1288154C Technical synthesis method for producing tropenol
12/06/2006CN1288138C 4,5-disubstituted-1,8-naphthoyl imide compounds and use thereof
12/06/2006CN1288137C 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone
12/05/2006US7145011 Reacting aniline compound and glyoxylic acid and olefin in solvent; applying microwave radiation
12/05/2006US7145010 Tert-alkylphenoxy-substituted polycyclic compounds
12/05/2006US7144882 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
12/05/2006CA2150382C Process for the preparation of 9-amino camptothecin
11/2006
11/30/2006WO2006125812A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
11/30/2006CA2604165A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
11/29/2006EP1726592A1 Dioxino derivatives and their use as dopanine agonists
11/29/2006EP1725545A1 Composition comprising an optically-active monomeric compound, method implementing said composition, monomeric compound, polymer comprising same, and use thereof
11/29/2006EP1725535A2 Hiv integrase inhibitors
11/29/2006EP1725534A1 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 110